Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark
One)
☑
QUARTERLY REPORT
UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the
quarterly period ended March 31, 2018
☐
TRANSITION REPORT
UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the
transition period _____
to______
Commission
file number 001-08675
UNITED STATES ANTIMONY CORPORATION
(Exact name of registrant as specified in its
charter)
Montana
|
|
81-0305822
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
P.O. Box 643, Thompson Falls, Montana
|
|
59873
|
(Address of
principal executive offices)
|
|
(Zip
code)
|
Registrant’s
telephone number, including area code: (406)
827-3523
Indicate
by check mark whether the issuer (1) filed all reports required to
be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes ☑ No
☐
Indicate
by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405
of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes ☑ No
☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of “large accelerated
filer,” “accelerated filer”, “small
reporting company” and “emerging growth company”
in Rule 12b-2 of the Exchange Act.
Large
Accelerated Filer ☐
|
Accelerated
Filer ☐
|
Non-Accelerated
Filer ☐
|
Smaller
reporting company ☑
|
|
Emerging
growth company ☐
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate
by check mark whether the registrant is a shell company as defined
by Rule 12b-2 of the Exchange Act. Yes ☐ No
☑
At May
15, 2018, the registrant had outstanding 68,227,171 shares of par
value $0.01 common stock.
UNITED STATES ANTIMONY CORPORATION
QUARTERLY REPORT ON FORM 10-Q
FOR THE PERIOD
ENDED MARCH 31, 2018
(UNAUDITED)
TABLE OF CONTENTS
|
Page
|
PART I – FINANCIAL INFORMATION
|
|
|
|
Item 1: Financial Statements (unaudited)
|
1-13
|
|
|
Item 2: Management’s Discussion and Analysis of Results of
Operations and Financial Condition
|
14-17
|
|
|
Item 3: Quantitative and Qualitative Disclosure about Market
Risk
|
17
|
|
|
Item 4: Controls and Procedures
|
18
|
|
|
PART II – OTHER INFORMATION
|
|
|
|
Item 1: Legal Proceedings
|
19
|
|
|
Item 2: Unregistered Sales of Equity Securities and Use of
Proceeds
|
19
|
|
|
Item 3: Defaults upon Senior Securities
|
19
|
|
|
Item 4: Mine Safety Disclosures
|
19
|
|
|
Item 5: Other Information
|
19
|
|
|
Item 6: Exhibits and Reports on Form 8-K
|
19 |
|
|
SIGNATURE
|
20
|
|
|
CERTIFICATIONS
|
|
[The
balance of this page has been intentionally left
blank.]
PART
I-FINANCIAL INFORMATION
Item 1. Financial Statements
United States Antimony Corporation and Subsidiaries
Consolidated Balance Sheets
March
31, 2018 and December 31, 2017
|
|
|
|
|
|
|
Current
assets:
|
|
|
Cash and cash
equivalents
|
$12,381
|
$27,987
|
Certificates of
deposit
|
252,717
|
252,298
|
Accounts
receivable, net
|
412,546
|
362,579
|
Inventories
|
641,094
|
914,709
|
Other current
assets
|
-
|
4,697
|
Total current
assets
|
1,318,738
|
1,562,270
|
|
|
|
Properties, plants
and equipment, net
|
14,950,140
|
15,132,897
|
Restricted cash for
reclamation bonds
|
63,345
|
63,345
|
IVA receivable and
other assets
|
418,351
|
372,742
|
Total
assets
|
$16,750,574
|
$17,131,254
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
Current
liabilities:
|
|
|
Checks issued and
payable
|
$11,045
|
$28,248
|
Accounts
payable
|
2,292,559
|
2,276,357
|
Due to
factor
|
12,750
|
10,880
|
Accrued payroll,
taxes and interest
|
195,298
|
185,283
|
Other accrued
liabilities
|
195,849
|
168,578
|
Payables to related
party
|
105,904
|
22,668
|
Deferred
revenue
|
60,165
|
60,049
|
Notes payable to
bank
|
97,117
|
192,565
|
Income taxes
payable (Note 11)
|
493,110
|
443,110
|
Long-term debt,
current portion, net of discount
|
598,658
|
546,988
|
Total current
liabilities
|
4,062,455
|
3,934,726
|
|
|
|
Long-term debt, net
of discount and current portion
|
1,159,895
|
1,239,126
|
Hillgrove advances
payable
|
1,134,196
|
1,134,221
|
Common stock
payable to directors for services
|
218,750
|
175,000
|
Asset retirement
obligations and accrued reclamation costs
|
273,109
|
271,572
|
Total
liabilities
|
6,848,405
|
6,754,645
|
Commitments and
contingencies (Note 7)
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
Preferred stock
$0.01 par value, 10,000,000 shares authorized:
|
|
|
Series A: -0-
shares issued and outstanding
|
-
|
-
|
Series B: 750,000
shares issued and outstanding
|
|
|
(liquidation
preference $909,375 and $907,500
|
|
|
respectively)
|
7,500
|
7,500
|
Series C: 177,904
shares issued and outstanding
|
|
|
(liquidation
preference $97,847 both years)
|
1,779
|
1,779
|
Series D: 1,751,005
shares issued and outstanding
|
|
|
(liquidation
preference $5,014,692 and $4,920,178
|
|
|
respectively)
|
17,509
|
17,509
|
Common stock, $0.01
par value, 90,000,000 shares authorized;
|
|
|
67,488,063 shares
issued and outstanding
|
674,881
|
674,881
|
Additional paid-in
capital
|
36,239,264
|
36,239,264
|
Accumulated
deficit
|
(27,038,764)
|
(26,564,324)
|
Total stockholders'
equity
|
9,902,169
|
10,376,609
|
Total liabilities
and stockholders' equity
|
$16,750,574
|
$17,131,254
|
|
|
|
The accompanying notes are an integral part of the consolidated
financial statements.
United
States Antimony Corporation and Subsidiaries
|
|
Consolidated
Statements of Operations - Unaudited
|
|
|
|
|
|
For the three
months ended
|
|
|
|
|
|
|
REVENUES
|
$2,432,929
|
$2,619,330
|
|
|
|
COST
OF REVENUES
|
2,488,017
|
2,529,786
|
|
|
|
GROSS
PROFIT (LOSS)
|
(55,088)
|
89,544
|
|
|
|
OPERATING
EXPENSES:
|
|
|
General
and administrative
|
150,831
|
200,592
|
Salaries
and benefits
|
91,446
|
97,487
|
Professional
fees
|
102,404
|
103,338
|
TOTAL
OPERATING EXPENSES
|
344,681
|
401,417
|
|
|
|
INCOME (LOSS) FROM
OPERATIONS
|
(399,769)
|
(311,873)
|
|
|
|
OTHER INCOME
(EXPENSE):
|
|
|
Interest
income
|
562
|
571
|
Interest
expense
|
(23,833)
|
(27,650)
|
Foreign exchange
gain (loss)
|
(50,000)
|
(41,451)
|
Factoring
expense
|
(1,400)
|
(10,900)
|
TOTAL
OTHER INCOME (EXPENSE)
|
(74,671)
|
(79,430)
|
|
|
|
NET
LOSS
|
(474,440)
|
(391,303)
|
Preferred
dividends
|
(12,162)
|
(12,162)
|
|
|
|
Net loss available
to common stockholders
|
$(486,602)
|
$(403,465)
|
|
|
|
Net income (loss)
per share of
|
|
|
common
stock:
|
|
|
Basic and
diluted
|
$(0.01)
|
$(0.01)
|
|
|
|
Weighted average
shares outstanding:
|
|
|
Basic
|
67,488,063
|
67,183,466
|
Diluted
|
67,488,063
|
67,183,466
|
The accompanying notes are an integral part of the consolidated
financial statements.
United
States Antimony Corporation and Subsidiaries
|
Consolidated
Statements of Cash Flows - Unaudited
|
|
For the three
months ended
|
Cash Flows From
Operating Activities:
|
|
|
Net income
(loss)
|
$(474,440)
|
$(391,303)
|
Adjustments to
reconcile net income (loss) to net cash
|
|
|
provided
(used) by operating activities:
|
|
|
Depreciation and
amortization
|
277,562
|
215,675
|
Amortization of
debt discount
|
21,120
|
23,413
|
Accretion of asset
retirement obligation
|
1,537
|
1,447
|
Common stock
payable for directors fees
|
43,750
|
43,750
|
Foreign exchange
loss
|
50,000
|
41,451
|
Other,
net
|
(444)
|
(426)
|
Change
in:
|
|
|
Accounts
receivable
|
(49,967)
|
(2,261)
|
Inventories
|
273,615
|
(55,386)
|
Other current
assets
|
4,697
|
17,918
|
IVA receivable and
other assets
|
(45,609)
|
(48,167)
|
Accounts
payable
|
16,202
|
324,508
|
Accrued payroll,
taxes and interest
|
10,015
|
(20,415)
|
Other accrued
liabilities
|
27,271
|
5,886
|
Deferred
revenue
|
116
|
-
|
Payables to related
party
|
8,236
|
(12,477)
|
Net cash provided
(used) by operating activities
|
163,661
|
143,613
|
|
|
|
Cash Flows From
Investing Activities:
|
|
|
Purchase of
properties, plants and equipment
|
(94,805)
|
(79,599)
|
Net cash used by
investing activities
|
(94,805)
|
(79,599)
|
|
|
|
Cash Flows From
Financing Activities:
|
|
|
Change in checks
issued and payable
|
(17,203)
|
(21,519)
|
Net borrowing from
factor
|
1,870
|
(4,388)
|
Advance from
related party
|
75,000
|
-
|
Proceeds from notes
payable to bank
|
-
|
15,985
|
Principal paid on
notes payable to bank
|
(95,448)
|
-
|
Principal payments
of long-term debt
|
(48,681)
|
(53,020)
|
Net cash provided
(used) by financing activities
|
(84,462)
|
(62,942)
|
NET INCREASE
(DECREASE) IN CASH
|
|
|
AND
CASH EQUIVALENTS
|
(15,606)
|
1,072
|
Cash and cash
equivalents and restricted cash at beginning of period
|
91,332
|
73,331
|
Cash and cash
equivalents and restricted cash at end of period
|
$75,726
|
$74,403
|
|
|
|
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION
|
|
|
Noncash investing
and financing activities:
|
|
|
Common stock
payable issued to directors
|
$-
|
$168,750
|
The accompanying notes are an integral part of the consolidated
financial statements.
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
The
unaudited consolidated financial statements have been prepared by
the Company in accordance with accounting principles generally
accepted in the United States of America for interim financial
information, as well as the instructions to Form 10-Q. Accordingly,
they do not include all of the information and footnotes required
by accounting principles generally accepted in the United States of
America for complete financial statements. In the opinion of the
Company’s management, all adjustments (consisting of only
normal recurring accruals) considered necessary for a fair
presentation of the interim financial statements have been
included. Operating results for the three month period ended March
31, 2018 are not necessarily indicative of the results that may be
expected for the full year ending December 31, 2018.
For
further information refer to the financial statements and footnotes
thereto in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2017.
Going Concern Consideration
At
March 31, 2018, the Company’s consolidated
financial statements show negative working capital of approximately
$2.7 million and accumulated deficit of approximately $27.0
million. In addition, the Company had reoccurring net
losses. These factors indicate that there may be doubt
regarding the ability to continue as a going concern for the next
twelve months.
The
continuing losses are principally a result of the Company’s
antimony operations and in particular to the production costs
incurred in Mexico.
Regarding the
antimony division, prices improved during 2017 with an average sale
price of $4.01 per pound. Through March 2018, the average sale
price for antimony is approximately $4.04 per pound. Additionally,
in November 2017, the Company renegotiated its domestic sodium
antimonite supply agreement resulting in a lower cost per antimony
per pound of approximately $0.44. During the first quarter of 2018,
we endured supply interruptions from our North American supplier,
but we anticipate that normal supply quantities will resume for the
remainder of 2018. With the new supply agreement in place, most of
the market increase in antimony prices is expected to result in
increased Company cash flow in 2018 from its antimony
division.
In
2017, the Company reduced costs for labor at the Mexico locations
which has resulted in a lower overall production costs in Mexico
which has continued into 2018. In the fourth quarter 2017, the
Company adjusted operating approaches at Madero that will likely
result in a decrease in operating costs for fuel, natural gas,
electricity, and reagents for 2018. Although total production
activity in Mexico decreased in 2017 due to the lack of Hillgrove
concentrates, the Company’s 2018 plan involves ramping up
production at its own antimony properties in Mexico. In addition, a
new leach circuit expected to come on line during 2018 in Mexico
will result in more extraction of precious metals. The portion of
the precious metals recovery system at the Madero smelter is
complete and the cyanide leach circuit being built at the Puerto
Blanco plant is in progress with completion expected this
fall.
In
2017, management implemented wage and other cost reductions at the
corporate level that will keep administrative costs stable in 2018.
The Company expects to continue paying a low cost for propane in
Montana, which in years past has been a major operating
cost.
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
1.
Basis
of Presentation, Continued:
Over the past several years, the Company has been
able to make required principal payments on its debt from cash
generated from operations without the need for additional
borrowings or selling shares of its common stock. The Company plans
to continue keeping current on its debt payments in 2018 through
cash flows from operations. Management believes that the actions
taken to increase production and reduce costs will enable the
Company meet its obligations for the next twelve
months.
2.
Developments
in Accounting Pronouncements
Accounting Standard Updates Adopted
In May
2014, the Financial Accounting Standards Board ("FASB") issued
Accounting Standards Update ("ASU") No. 2014-09 Revenue
Recognition, replacing guidance currently codified in Subtopic
605-10 Revenue Recognition-Overall. The new ASU establishes a new
five step principles-based framework in an effort to significantly
enhance comparability of revenue recognition practices across
entities, industries, jurisdictions, and capital markets. In August
2015, the FASB issued ASU No. 2015-14 Revenue from Contracts with
Customers (Topic 606): Deferral of the Effective Date. ASU No.
2015-14 deferred the effective date of ASU No. 2014-09 until annual
and interim reporting periods beginning after December 15, 2017. We
adopted ASU No. 2014-09 as of January 1, 2018 using the
modified-retrospective transition approach. There was no impact of
adoption of the update to our consolidated financial statements for
the three months ended March 31, 2018.
We
performed an assessment of the impact of implementation of ASU No.
2014-09, and concluded it does not change the timing of revenue
recognition or amounts of revenue recognized compared to how we
recognize revenue under our current policies. Adoption of ASU No.
2014-09 involves additional disclosures, where applicable, on (i)
contracts with customers, (ii) significant judgments and changes in
judgments in determining the timing of satisfaction of performance
obligations and the transaction price, and (iii) assets recognized
for costs to obtain or fulfill contracts. See Note 4 for
information on our sales of products.
In
August 2016, the FASB issued ASU No. 2016-15 Statement of Cash
Flows (Topic 230): Classification of Certain Cash Receipts and Cash
Payments. The update provides guidance on classification for cash
receipts and payments related to eight specific issues. The update
is effective for fiscal years beginning after December 15, 2017,
and interim periods within those fiscal years, with early adoption
permitted. We adopted this update as of January 1,
2018.
In
November 2016, the FASB issued ASU No. 2016-18 Statement of Cash
Flows (Topic 230): Restricted Cash. The update requires that a
statement of cash flows explain the change during the period in the
total of cash, cash equivalents, and amounts generally described as
restricted cash or restricted cash equivalents. The update is
effective for fiscal years beginning after December 15, 2017, and
interim periods within those fiscal years, with early adoption
permitted. We adopted this update as of January 1, 2018. Cash, cash
equivalents, and restricted cash on the consolidated statements of
cash flows includes restricted cash of $63,345 as of March 31, 2018
and December 31, 2017 and $63,274 as of March 31, 2017 and December
31, 2016, as well as amounts previously reported for cash and cash
equivalents.
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
2.
Developments
in Accounting Pronouncements, Continued:
Accounting Standards Updates to Become Effective in Future
Periods
In
February 2016, the FASB issued ASU No. 2016-02 Leases (Topic 842).
The update modifies the classification criteria and requires
lessees to recognize the assets and liabilities on the balance
sheet for most leases. The update is effective for fiscal years
beginning after December 15, 2018, with early adoption permitted.
We are currently reviewing our leases and compiling the information
required to implement the new guidance. See Note 7 for information
on future commitments related to our operating leases; the present
value of these leases will be recognized on our balance sheet upon
implementation of the new guidance. We are currently evaluating the
potential impact of implementing this update on our consolidated
financial statements.
3.
Income
(Loss) Per Common Share
Basic
earnings per share is calculated by dividing net income (loss)
available to common stockholders by the weighted average number of
common shares outstanding during the period. Diluted earnings per
share is calculated based on the weighted average number of common
shares outstanding during the period plus the effect of potentially
dilutive common stock equivalents, including warrants to purchase
the Company's common stock and convertible preferred stock.
Management has determined that the calculation of diluted earnings
per share for the quarters ended March 31, 2018 and March 31, 2017,
is not applicable since any additions to outstanding shares related
to common stock equivalents would be anti-dilutive.
As of
March 31, 2018 and 2017, the potentially dilutive common stock
equivalents not included in the calculation of diluted earnings per
share as their effect would have been anti-dilutive are as
follows:
|
|
|
Warrants
|
250,000
|
250,000
|
Convertible
preferred stock
|
1,751,005
|
1,751,005
|
Total possible
dilution
|
2,001,005
|
2,001,005
|
Our
products consist of the following:
●
Antimony: includes
antimony oxide, sodium antimonate, and
antimony metal
●
Zeolite:
includes course and fine zeolite crushed in various
sizes.
●
Precious Metals: includes refined gold and
silver
For our
antimony and zeolite products, revenue is recognized upon the
completion of the performance obligation which is met when the
transaction price can be reasonably estimated and revenue is
recognized generally at the time when risk is transferred. We have
determined the performance obligation is met and title is
transferred either upon shipment from our warehouse locations or
upon receipt by the customer as specified in individual sales
orders. The performance obligation is met because at that time, 1)
legal title is transferred to the customer, 2) the customer has
accepted the product and obtained the ability to realize all of the
benefits from the product, 3) the customer has the significant
risks and rewards of ownership to it, 4) it is very unlikely
product will be rejected by the customer upon physical receipt, and
5) we have the right to payment for the product. Shipping costs
related to the sales of antimony and zeolite products are recorded
to cost of sales as incurred. For zeolite products, royalty expense
due a third party by the Company is also recorded to cost of sales
upon sale in accordance with terms of underlying royalty
agreements.
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
4.
Revenue
Recognition, continued
For
sales of precious metals, the performance obligation is met, the
transaction price is known, and revenue is recognized at the time
of transfer of control of the agreed-upon metal quantities to the
customer. Refining and shipping costs related to sales of precious
metals are recorded to cost of sales as incurred.
Sales
of products for the thee-month periods ended March 31, 2018
and 2017 were as follows:
|
|
|
|
|
|
|
Antimony
|
$1,681,812
|
$1,986,507
|
Zeolite
|
690,707
|
612,012
|
Precious
metals
|
60,410
|
20,811
|
|
$2,432,929
|
$2,619,330
|
The
following is sales information by geographic area based on the
location of customers for the three-month periods ended
March 31, 2018 and 2017:
|
|
|
|
|
|
|
United
States
|
$2,099,521
|
$2,297,055
|
Canada
|
185,238
|
322,275
|
Mexico
|
148,170
|
-
|
|
$2,432,929
|
$2,619,330
|
Sales
of products to significant customers were as follows for the
three-month periods ended March 31, 2018 and
2017:
Sales
to Three
|
|
Largest
Customers
|
|
|
Kohler
Corporation
|
$316,772
|
$445,178
|
Ampacet
Corporation
|
184,142
|
-
|
East Penn
Manufacturing
|
-
|
148,643
|
Mexichem Speciality
Compounds
|
728,578
|
786,425
|
|
$1,229,492
|
$1,380,246
|
%
of Total Revenues
|
50.50%
|
52.70%
|
Three
Largest
|
|
|
Accounts
Receivable
|
|
|
Kohler
Corporation
|
|
$149,124
|
Axens North America
Inc.
|
$38,404
|
-
|
Mexichem Speciality
Compounds
|
148,170
|
135,680
|
Teck
America
|
59,110
|
-
|
Nutreco Canada
Inc.
|
-
|
28,139
|
|
$245,684
|
$312,943
|
%
of Total Receivables
|
59.50%
|
56.50%
|
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
4.
Revenue
Recognition, continued:
Our
trade accounts receivable balance related to contracts with
customers was $412,546 at March 31, 2018 and $362,579 at
December 31, 2017. Our products do not involve any warranty
agreements and product returns are not typical.
We have
determined our contracts do not include a significant financing
component. For antimony and zeolite sales contracts, we may factor
certain receivables and receive final payment within 30 days of the
performance obligation being met. For antimony and zeolite
receivables not factored, we typically receive payment within 10
days. For precious metals sales, a provisional payment of 75% is
typically received within 45 days of the date the product is
delivered to the customer. After an exchange of assays, a final
payment is normally received within 90 days of product
delivery.
We do
not incur significant costs to obtain contracts, or costs to
fulfill contracts which are not addressed by other standards.
Therefore, we have not recognized an asset for such costs as of
March 31, 2018 or December 31, 2017.
Inventories at
March 31, 2018 and December 31, 2017 consisted primarily of
finished antimony products, antimony metal, antimony ore, and
finished zeolite products that are stated at the lower of first-in,
first-out cost or estimated net realizable value. Finished antimony
products, antimony metal and finished zeolite products costs
include raw materials, direct labor and processing facility
overhead costs and freight. Inventory at March 31, 2018 and
December 31, 2017, is as follows:
|
|
|
|
|
|
Antimony
Metal
|
$3,580
|
$-
|
Antimony
Oxide
|
215,778
|
408,217
|
Antimony
Concentrates
|
11,545
|
35,554
|
Antimony
Ore
|
151,841
|
187,133
|
Total
antimony
|
382,744
|
630,904
|
Zeolite
|
258,350
|
283,805
|
|
$641,094
|
$914,709
|
6.
Accounts
Receivable and Due to Factor
The
Company factors designated trade receivables pursuant to a
factoring agreement with LSQ Funding Group L.C., an unrelated
factor (the “Factor”). The agreement
specifies that eligible trade receivables are factored with
recourse. We submit selected trade receivables to the factor, and
receive 83% of the face value of the receivable by wire transfer.
The Factor withholds 15% as retainage, and 2% as a servicing fee.
Upon payment by the customer, we receive the remainder of the
amount due from the factor. The 2% servicing fee is recorded on the
consolidated statement of operations in the period of sale to the
factor. John Lawrence, CEO, is a personal guarantor of the
amount due to Factor.
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
6.
Accounts
Receivable and Due to Factor, Continued:
Trade
receivables assigned to the Factor are carried at the original
invoice amount less an estimate made for doubtful
accounts. Under the terms of the recourse provision, the
Company is required to reimburse the Factor, upon demand, for
factored receivables that are not paid on
time. Accordingly, these receivables are accounted for
as a secured financing arrangement and not as a sale of financial
assets. The allowance for doubtful accounts (if any) is based
on management’s regular evaluation of individual
customer’s receivables and consideration of a
customer’s financial condition and credit
history. Trade receivables are written off when deemed
uncollectible. Recoveries of trade receivables
previously written off are recorded when
received. Interest is not charged on past due
accounts.
We
present the receivables, net of allowances, as current assets and
we present the amount potentially due to the Factor as a secured
financing in current liabilities.
Accounts
Receivble
|
|
|
Accounts receivable
- non factored
|
$399,796
|
$351,699
|
Accounts receivable
- factored with recourse
|
12,750
|
10,880
|
Accounts
receivable - net
|
$412,546
|
$362,579
|
7.
Commitments
and Contingencies
In June
of 2013, the Company entered into a lease to mine antimony ore from
concessions located in the Wadley Mining district in Mexico. The
lease calls for a term of one year and, and as of March 31, 2018,
requires payments of $10,000 plus a tax of $1,700, per month. The
lease is renewable each year with a 15 day notice to the lessor,
and agreement of terms. The next lease is scheduled for renewal in
June 2018.
At March 31, 2018 and
December 31, 2017, the Company had the following notes payable to
bank:
|
|
|
|
|
|
|
|
Promissory note
payable to First Security Bank of Missoula,
|
|
|
bearing interest at
3.150%, payable on demand, collateralized
|
|
|
by a lien on
Certificate of Deposit
|
$15,815
|
$98,863
|
|
|
|
Promissory note
payable to First Security Bank of Missoula,
|
|
|
bearing interest at
3.150%, payable on demand, collateralized
|
|
|
by a lien on
Certificate of Deposit
|
81,302
|
93,702
|
Total notes payable
to the bank
|
$97,117
|
$192,565
|
These
notes are personally guaranteed by John C. Lawrence the
Company’s Chief Executive Officer and Chairman of the Board
of Directors. The maximum amount available for borrowing under each
note is $99,999.
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
Debt at March 31,
2018 and December 31, 2017 is as follows:
|
|
|
|
|
|
Note payable to
First Security Bank, bearing interest at 6%;
|
|
|
payable in monthly
installments of $917; maturing
|
|
|
September 2018;
collateralized by equipment.
|
$5,408
|
$8,054
|
Note payable to Cat
Financial Services, bearing interest at 6%;
|
|
|
payable in monthly
installments of $1,300; maturing
|
|
|
August 2019;
collateralized by equipment.
|
23,602
|
27,096
|
Note payable to Cat
Financial Services, bearing interest at 6%;
|
|
|
payable in monthly
installments of $778; maturing
|
|
|
December 2022;
collateralized by equipment.
|
39,145
|
40,278
|
Note payable to De
Lage Landen Financial Services,
|
|
|
bearing interest at
3.51%; payable in monthly installments of $655;
|
|
|
maturing September
2019; collateralized by equipment.
|
10,875
|
13,344
|
Note payable to De
Lage Landen Financial Services,
|
|
|
bearing interest at
3.51%; payable in monthly installments of $655;
|
|
|
maturing December
2019; collateralized by equipment.
|
13,337
|
15,776
|
Note payable to
Phyllis Rice, bearing interest
|
|
|
at 1%; payable in
monthly installments of $2,000; maturing
|
|
|
March 2015;
collateralized by equipment.
|
14,146
|
14,146
|
Obligation payable
for Soyatal Mine, non-interest bearing,
|
|
|
annual
payments of $100,000 or $200,000 through 2019, net of
discount.
|
702,469
|
715,709
|
Obligation payable
for Guadalupe Mine, non-interest bearing,
|
|
|
annual
payments from $60,000 to $149,078 through 2026, net of
discount.
|
949,571
|
951,711
|
|
1,758,553
|
1,786,114
|
Less current
portion
|
(598,658)
|
(546,988)
|
Long-term
portion
|
$1,159,895
|
$1,239,126
|
At
March 31, 2018, principal payments on debt are due as
follows:
Twelve
months ending March 31,
|
|
2019
|
$598,658
|
2020
|
283,237
|
2021
|
181,043
|
2022
|
116,915
|
2023
|
122,406
|
Thereafter
|
456,294
|
|
$1,758,553
|
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
10.
Related
Party Transactions
During
the three months ended March 31, 2018 and 2017, the Chairman of the
audit committee and compensation committee received $4,500 and
$4,500, respectively, for services performed. See Note 12 for
shares of common stock issued to directors.
During
the three months ended March 31, 2018 and 2017, the Company paid
$2,461 and $2,895, respectively, to John Lawrence, our President
and Chief Executive Officer, as reimbursement for equipment used by
the Company. Mr. Lawrence advanced the Company $75,000 for ongoing
operating expenses during the three months ended March 31, 2018
which is still outstanding at March 31, 2018 and is included in
payable to related party.
During the quarter ended March 31, 2018, and the
year ended December 31, 2017, the Company determined that a
valuation allowance equal to 100% of any deferred tax asset was
appropriate, as management of the Company cannot determine that it
is more likely than not the Company will realize the benefit of a
net deferred tax asset. The net effect is that the deferred tax
asset as of December 31, 2017, and any deferred tax assets that may
have been incurred since then, are fully reserved for at March 31,
2018. Management estimates the effective tax rate at 0% for
the current year.
Mexican Tax
Assessment
In
2015, the Mexican tax authority (“SAT”) initiated an
audit of the USAMSA’s 2013 income tax return. In October
2016, as a result of its audit, SAT assessed the Company $13.8
million pesos, which was approximately $666,400 in U.S. Dollars
(“USD”) as of December 31, 2016. Approximately $285,000
USD of the total assessment is interest and penalties. SAT’s
assessment is based on the disallowance of specific costs that the
Company deducted on the 2013 USAMSA income tax return. These
disallowed costs were incurred by the Company for USAMSA’s
business operations. SAT claims that the costs were not deductible
or were not supported by appropriate documentation. At March 31,
2018, the assessed amount is $757,247 in U.S dollars.
Management
has reviewed the assessment notice from SAT and believes numerous
findings have no merit. The Company has engaged accountants and tax
attorneys in Mexico to defend its position. An appeal has been
filed.
At
December 31, 2016, management estimated possible outcomes for this
assessment and believes it will ultimately pay an amount ranging
from 30% of the total assessment to the total assessed amount. The
Company’s agreement with the tax professionals is that the
professionals will receive 30% of the amount of tax relief they are
able to achieve.
At
December 31, 2016, the Company accrued a potential liability of
$410,510 USD of which $285,048 was for unpaid income taxes, $75,510
was for interest expense, and $49,952 was for penalties. The amount
accrued represents management’s best estimate of the amount
that will ultimately be paid. The outcome could vary from this
estimate. At March 31, 2018, the Company recognized a $50,000
increase due to the change in exchange rate. Fluctuation in
exchange rates has an ongoing impact on the amount the Company will
pay in U.S. dollars.
If
an issue addressed during the SAT audit is resolved in a manner
inconsistent with management expectations, the Company will adjust
its net operating loss carryforward, or accrue any additional
penalties, interest, and tax associated with the audit. The
Company’s tax professionals in Mexico have reviewed and filed
tax returns with the SAT for other tax years and have advised the
Company that they do not expect the Company to have a tax liability
for those years relating to similar issues.
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
Issuance of Common Stock for Payable to Board of
Directors
During
the quarter ended March 31, 2017, the Board of Directors was issued
a total of 421,875 shares of common stock for $168,750 in
directors’ fees that were payable at December 31, 2016. In
addition during the quarter, the Company accrued $43,750 in
directors’ fees payable that will be paid in common
stock.
On May
3, 2018, the Board of Directors was issued a total of 739,018
shares of common stock for $175,000 in directors’ fees that
were payable at December 31, 2017. In addition, during the quarter
ended March 31, 2018, the Company accrued $43,750 in
directors’ fees payable that will be paid in common
stock.
The
Company is currently organized and managed by four segments, which
represent our operating units: United States antimony operations,
Mexican antimony operations, precious metals recovery and United
States zeolite operations.
The
Madero smelter and Puerto Blanco mill at the Company’s Mexico
operation brings antimony up to an intermediate stage, which may be
sold directly or shipped to the United States operation for
finishing and sales at the Thompson Falls, Montana plant. The
precious metals recovery plant is operated in conjunction with the
antimony processing plant at Thompson Falls, Montana. The Zeolite
operation produces Zeolite near Preston, Idaho. Almost all of the
sales of products from the United States antimony and Zeolite
operations are to customers in the United States.
Segment
disclosure regarding sales to major customers is located in Note
4.
Properties,
plants and
equipment, net:
|
|
|
Antimony
|
|
|
United
States
|
$1,674,787
|
$1,687,997
|
Mexico
|
11,343,589
|
11,452,507
|
Subtotal
Antimony
|
13,018,376
|
13,140,504
|
Precious
metals
|
616,233
|
642,774
|
Zeolite
|
1,315,531
|
1,349,619
|
Total
|
$14,950,140
|
$15,132,897
|
|
|
|
Total
Assets:
|
|
|
Antimony
|
|
|
United
States
|
$2,225,360
|
$2,510,323
|
Mexico
|
12,009,001
|
12,073,219
|
Subtotal
Antimony
|
14,234,361
|
14,583,542
|
Precious
metals
|
616,233
|
642,774
|
Zeolite
|
1,899,980
|
1,904,938
|
Total
|
$16,750,574
|
$17,131,254
|
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited),
Continued:
13.
Business
Segments, Continued:
|
For the three
months ended
|
Capital
expenditures:
|
|
|
Antimony
|
|
|
United
States
|
$-
|
$-
|
Mexico
|
40,085
|
28,683
|
Subtotal
Antimony
|
40,085
|
28,683
|
Precious
Metals
|
40,988
|
43,000
|
Zeolite
|
13,732
|
7,916
|
Total
|
$94,805
|
$79,599
|
Segment
Operations for the three
|
|
|
|
|
|
|
months
ended March 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
revenues
|
$1,681,812
|
$-
|
$1,681,812
|
$60,410
|
$690,707
|
$2,432,929
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
13,209
|
149,004
|
162,213
|
67,529
|
47,820
|
277,562
|
|
|
|
|
|
|
|
Income (loss) from
operations
|
198,039
|
(742,781)
|
(544,742)
|
(7,119)
|
152,092
|
(399,769)
|
|
|
|
|
|
|
|
Other income
(expense):
|
(778)
|
(71,120)
|
(71,898)
|
-
|
(2,773)
|
(74,671)
|
|
|
|
|
|
|
|
NET
INCOME (LOSS)
|
$197,261
|
$(813,901)
|
$(616,640)
|
$(7,119)
|
$149,319
|
$(474,440)
|
|
|
|
|
|
|
|
Segment
Operations for the three
|
|
|
|
|
|
|
months
ended March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
revenues
|
$1,968,725
|
$17,782
|
$1,986,507
|
$20,811
|
$612,012
|
$2,619,330
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
19,500
|
146,175
|
165,675
|
-
|
50,000
|
215,675
|
|
|
|
|
|
|
|
Income (loss) from
operations
|
328,900
|
(751,176)
|
(422,276)
|
20,811
|
89,592
|
(311,873)
|
|
|
|
|
|
|
|
Other income
(expense):
|
(11,078)
|
(64,965)
|
(76,043)
|
-
|
(3,387)
|
(79,430)
|
|
|
|
|
|
|
|
NET
INCOME (LOSS)
|
$317,822
|
$(816,141)
|
$(498,319)
|
$20,811
|
$86,205
|
$(391,303)
|
ITEM
2. Management’s Discussion and Analysis of
Results of Operations and Financial Condition
General
Certain
matters discussed are forward-looking statements that involve risks
and uncertainties, including the impact of antimony prices and
production volatility, changing market conditions and the
regulatory environment and other risks. Actual results may differ
materially from those projected. These forward-looking statements
represent our judgment as of the date of this filing. We disclaim,
however, any intent or obligation to update these forward-looking
statements.
|
|
|
and
Mexico
|
|
|
Lbs of Antimony
Metal USA
|
263,620
|
459,666
|
Lbs of Antimony
Metal Mexico:
|
152,344
|
88,184
|
Total
Lbs of Antimony Metal Sold
|
415,964
|
547,850
|
Average Sales
Price/Lb Metal
|
$4.04
|
$3.63
|
Net
loss/Lb Metal
|
$(1.48)
|
$(0.88)
|
|
|
|
Gross antimony
revenue - net of discount
|
$1,681,812
|
$1,986,507
|
|
|
|
Cost of sales -
domestic
|
(1,190,034)
|
(1,282,872)
|
Cost of sales -
Mexico
|
(715,968)
|
(731,457)
|
Operating
expenses
|
(320,552)
|
(418,894)
|
Non-operating
expenses
|
(71,898)
|
(34,592)
|
|
(2,298,452)
|
(2,467,815)
|
|
|
|
Net
loss - antimony
|
(616,640)
|
(481,308)
|
Depreciation,&
amortization
|
162,213
|
148,664
|
EBITDA
- antimony
|
$(454,427)
|
$(332,644)
|
|
|
|
Precious
Metals
|
|
|
Ounces
sold
|
|
|
Gold
|
12
|
82
|
Silver
|
4,073
|
8,639
|
|
|
|
Gross precious
metals revenue
|
$60,410
|
$187,477
|
Production costs,
royalties, and shipping costs
|
(67,529)
|
(183,677)
|
Net
income - precious metals
|
(7,119)
|
3,800
|
Depreciation
|
67,529
|
17,011
|
EBITDA
- precious metals
|
$60,410
|
$20,811
|
|
|
|
Zeolite
|
|
|
Tons
sold
|
3,753
|
3,353
|
Average Sales
Price/Ton
|
$184.04
|
$182.53
|
Net
income (Loss)/Ton
|
$39.79
|
$25.71
|
|
|
|
Gross zeolite
revenue
|
$690,707
|
$612,012
|
Cost of
sales
|
(514,486)
|
(498,446)
|
Operating
expenses
|
(24,129)
|
(23,975)
|
Non-operating
expenses
|
(2,773)
|
(3,386)
|
Net
income - zeolite
|
149,319
|
86,205
|
Depreciation
|
47,820
|
50,000
|
EBITDA
- zeolite
|
$197,139
|
$136,205
|
|
|
|
Company-wide
|
|
|
Gross
revenue
|
$2,432,929
|
$2,785,996
|
Production
costs
|
(2,488,017)
|
(2,696,452)
|
Operating
expenses
|
(344,681)
|
(442,869)
|
Non-operating
expenses
|
(74,671)
|
(37,978)
|
Net
income (loss)
|
(474,440)
|
(391,303)
|
Depreciation,&
amortization
|
277,562
|
215,675
|
EBITDA
|
$(196,878)
|
$(175,628)
|
PART I - FINANCIAL INFORMATION, CONTINUED:
ITEM
2. Management’s Discussion and Analysis of Results of
Operations and Financial Condition, continued:
Company-Wide
For the
first quarter of 2018, we recognized a net loss of $474,440, on
sales of $2,432,929, compared to a net loss of $391,303 in the
first quarter of 2017 on sales of $2,619,330. The loss in the first
Quarter of 2018 was primarily due to a decrease in the raw
materials received from our North American supplier. The loss in
the first quarter of 2017 was primarily due to the loss of raw
material from Hillgrove Mines of Australia. We also recognized
approximately $124,732 of settlement costs related to our precious
metals production during the first quarter of 2017. Hillgrove Mines
has given us permission to use the LRF and other furnaces built for
their use for our own production. During the first quarter of 2018,
we endured supply interruptions from our North American supplier,
but we anticipate that normal supply quantities will resume for the
remainder of 2018.
For the first
quarter of 2018, EBITDA was a negative $196,878 compared to a
negative $175,628 for the same period of 2017.
Net
non-cash expense items totaled $343,969 for the first quarter of
2018 and included $277,562 for depreciation and amortization,
$21,120 for amortization of debt discount, $43,750 for director
compensation and $1,537 for other items.
Net
non-cash expense items totaled $284,285 for 2017 and included
$215,675 for depreciation and amortization, $23,413 for
amortization of debt discount, $43,750 for director compensation
and $1,447 for other items.
For the
first quarter of 2018, general and administrative expenses were
$150,831 compared to $200,592 for the same period of
2017.
Antimony
For the
first quarter of 2018 we sold 415,964 pounds of antimony compared
to 547,850 pounds for the first quarter of 2017. Our raw material
from North America decreased by approximately 196,000 pounds, but
was partially offset by an increase of approximately 64,000 pounds
in raw material from Mexico.
We
began the mining and processing of ore from our own Mexican mines
during Q1of 2017 and produced 132,184 pounds and sold 88,184
pounds. For the first quarter of 2018, we produced and sold 152,344
pounds of antimony. Producing from our own Mexican mines will allow
the Company to benefit from 100% of the price increases rather than
a processing fee and a small percent of the price
increases.
The
average sales price of antimony during Q1 2018 was $4.04 per pound
compared to $3.63 during the same period in 2017.
The
cyanide leach circuit at Puerto Blanco has been permitted, and
construction of the leach circuit is underway.
At the
Wadley mine, production is being increased with more miners. The
use of pneumatic hammers is planned in lieu of
explosives.
PART I - FINANCIAL INFORMATION, CONTINUED:
ITEM
2. Management’s Discussion and Analysis of Results of
Operations and Financial Condition, continued:
Precious Metals
The
caustic leach of flotation concentrates from Los Juarez was
successful, and the pilot production of the Los Juarez gold,
silver, and antimony will commence with the completion of the
cyanide leach plant at Puerto Blanco.
Precious Metal Sales Silver/Gold
|
For the three months ended March 31,
|
Montana
|
|
|
Ounces Gold
Shipped (Au)
|
11.59
|
24.60
|
Ounces Silver
Shipped (Ag)
|
4,073.27
|
8,639.39
|
Revenues
|
$60,410
|
$133,506
|
Australian - Hillgrove
|
|
|
Ounces Gold
Shipped (Au)
|
-
|
57.25
|
Revenues -
Gross
|
-
|
$53,971
|
Revenues to
Hillgrove
|
-
|
(166,666)
|
Revenues to
USAC
|
-
|
$(112,695)
|
|
|
|
Total Revenues
|
$60,410
|
$20,811
|
The
estimated recovery of precious metals per metric ton, after the
caustic leach and cyanide leach circuits, is as
follows:
[Insert
Image]
Bear River Zeolite (BRZ)
During
Q1 2018, BRZ sold 3,753 tons of zeolite compared to 3,353 tons in
the same period of 2017, up 400 tons or 11.9%.
BRZ
realized a profit of $149,319 in Q1 of 2018, compared to $86,205 in
Q1of 2017. The increase in profit from our zeolite operations was
$63,144 (73.2%).
BRZ
realized an EBITDA for Q1of 2018 of $197,139, compared to $136,205
for the same period in 2017, an increase of $60,934
(44.7%).
PART I - FINANCIAL INFORMATION, CONTINUED:
ITEM
2. Management’s Discussion and Analysis of Results of
Operations and Financial Condition, continued:
Financial Position
Financial
Condition and Liquidity
|
|
|
|
|
|
Current
assets
|
$1,318,738
|
$1,562,270
|
Current
liabilities
|
(4,062,455)
|
(3,934,726)
|
Net
working capital
|
$(2,743,717)
|
$(2,372,456)
|
|
|
|
|
|
|
|
|
|
Cash provided
(used) by operations
|
$163,661
|
$143,613
|
Cash used in
investing
|
(94,805)
|
(79,599)
|
Cash provided
(used) by financing:
|
|
|
Net
proceeds (payments to) factor
|
1,870
|
(4,388)
|
Advance
from related party
|
75,000
|
-
|
Proceeds
from notes payable to bank
|
-
|
15,985
|
Change
in check issued and payable
|
(17,203)
|
(21,519)
|
Payment
of notes payable to bank
|
(95,448)
|
-
|
Principal
paid on long-term debt
|
(48,681)
|
(53,020)
|
Net
change in cash
|
$(15,606)
|
$1,072
|
Our net
working capital decreased by approximately $370,000 from December
31, 2017. Our cash decreased by approximately $15,600 during the
same period. The decrease in our net working capital was primarily
due to an increase of approximately $50,000 in the current portion
of long term debt, and an increase of approximately $50,000 for
foreign income taxes due to foreign exchange rates, a decrease in
inventories of approximately $275,000 and expenditures of
approximately $95,000 for capital outlay. We have estimated
commitments for construction and improvements of $100,000,
including $50,000 to finish building and installing the precious
metals leach circuits. We believe that with our current cash
balance, along with the future cash flow from operations, we have
adequate liquid assets to meet these commitments and service our
debt for the next twelve months. We have lines of credit of
$202,000 which have been drawn down to $97,117 at March 31,
2018.
ITEM 3.
None
PART I - FINANCIAL INFORMATION, CONTINUED:
Management’s
Discussion and Analysis of Results of Operations and Financial
Condition, continued:
ITEM
4. Controls and Procedures
EVALUATION OF
DISCLOSURE CONTROLS AND PROCEDURES
We
maintain disclosure controls and procedures that are designed to
ensure that information required to be disclosed in our reports
under the Securities Exchange Act of 1934 is recorded, processed,
summarized and reported within the time periods specified in the
SEC's rules and forms, and that such information is accumulated and
communicated to management, as appropriate, to allow timely
decisions regarding required disclosure. Our chief financial
officer conducted an evaluation of the effectiveness of the
Company's disclosure controls and procedures (as defined in the
Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as
of March 31, 2018. It was determined that there were material
weaknesses affecting our disclosure controls and procedures and, as
a result of those weaknesses, our disclosure controls and
procedures were not effective as of March 31, 2018. These material
weaknesses are as follows:
●
Inadequate design
of internal control over the preparation of the financial
statements and financial reporting processes;
●
Inadequate
monitoring of internal controls over significant accounts and
processes including controls associated with domestic and Mexican
subsidiary operations and the period-end financial reporting
process; and
●
The absence of
proper segregation of duties within significant processes and
ineffective controls over management oversight, including antifraud
programs and controls.
We are
aware of these material weaknesses and will develop procedures to
ensure that independent review of material transactions is
performed. The chief financial officer will develop internal
control measures to mitigate the lack of inadequate documentation
of controls and the monitoring of internal controls over
significant accounts and processes including controls associated
with the period-ending reporting processes, and to mitigate the
segregation of duties within significant accounts and processes and
the absence of controls over management oversight, including
antifraud programs and controls.
We plan
to consult with independent experts when complex transactions are
entered into.
CHANGES
IN INTERNAL CONTROL OVER FINANCIAL REPORTING
There were no significant changes made to
internal controls over financial reporting for the quarter ended
March 31, 2018.
PART
II - OTHER INFORMATION
Item
1. LEGAL PROCEEDINGS
None
Item
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
None
Item
3. DEFAULTS UPON SENIOR SECURITIES
The
registrant has no outstanding senior securities.
Item
4. MINE SAFETY DISCLOSURES
The
information concerning mine safety violations or other regulatory
matters required by Section 1503 (a) of the Dodd-Frank Wall Street
Reform and Consumer Protection Act and Item 104 of Regulation S-K
is included in Exhibit 95 to this Annual Report.
Item
5. OTHER INFORMATION
None
Item
6. EXHIBITS AND REPORTS ON FORM 8-K
Certifications
Certifications
Pursuant to the Sarbanes-Oxley Act
Reports on Form
8-K None
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(b) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly
authorized.
UNITED
STATES ANTIMONY CORPORATION
(Registrant)
|
|
|
|
Date: May 15,
2018
|
By:
|
/s/
John C.
Lawrence
|
|
|
|
John C.
Lawrence, Director and President |
|
|
|
(Principal
Executive) |
|
|
|
|
|
Date: May 15,
2018
|
By:
|
/s/
Daniel
L. Parks, Chief Financial Officer
|
|
|
|
Daniel
L. Parks, Chief Financial Officer |
|
|
|
|
|